Financhill
Back

Evogene Ltd. Stock Predictions

Evogene Ltd. Stock Forecast

  • Is Evogene Ltd. Stock Undervalued?
    The current Evogene Ltd. [EVGN] share price is $0.97. The Score for EVGN is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • EVGN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Evogene Ltd. Stock Go Up Next Year?

Data Unavailable

Evogene Ltd. Stock Rating

Data Unavailable

Evogene Ltd. Stock Price History

Is EVGN stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EVGN is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Israel
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
evogene.com

52-Week Data

52-Week High:
2.42
52-Week Low:
0.95

Prediction Charts

Market Cap:
8.5M
Price in USD:
0.97
Volume:
87.7K
Beta:
1.09

Technical Analysis

SMA50:
1.15
SMA100:
1.20
SMA200:
1.23
52-Wk Change:
-41.19%

Stock Predictions

  • Is Evogene Ltd. stock public?
    Yes, Evogene Ltd. is a publicly traded company.
  • What is the Evogene Ltd. stock quote today?
    The Evogene Ltd. stock price is 0.97 USD today.
  • How to buy Evogene Ltd. stock online?
    You can buy Evogene Ltd. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-8 1.10 1.15 1.19 1.09
Dec-9 1.13 1.09 1.16 1.09
Dec-10 1.10 1.10 1.10 1.07
Dec-11 1.10 1.09 1.10 1.08
Dec-12 1.10 1.08 1.12 1.08
Dec-15 1.08 1.05 1.09 1.04
Dec-16 1.06 1.05 1.07 1.03
Dec-17 1.03 1.01 1.06 1.01
Dec-18 1.04 0.99 1.04 0.98
Dec-19 0.97 1.02 1.02 0.96
Dec-22 1.02 1.03 1.06 0.97
Dec-24 1.05 1.05 1.06 1.02
Dec-26 1.05 1.04 1.05 1.01
Dec-29 0.99 0.97 1.01 0.96

Evogene Ltd. Earnings

Data Unavailable

Evogene Ltd. Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.73 per share, and a decrease next year of $0.00 per share.

* Evogene Ltd. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.